Depletion of Baz2A has been studied in NIH3T3 and COS cells, where an increase in ribosome production and cell proliferation was observed, whereas in metastatic prostate cancer cell lines, Baz2A paradoxically contributes to cancer cell proliferation and viability (38,80,81). The gene discussed is BAZ2A; the disease is metastatic prostate carcinoma.